0000899243-17-018665.txt : 20170720 0000899243-17-018665.hdr.sgml : 20170720 20170720210901 ACCESSION NUMBER: 0000899243-17-018665 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170718 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHONEY DAVID L CENTRAL INDEX KEY: 0001224091 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 17975386 MAIL ADDRESS: STREET 1: SYMANTEC CORPORATION STREET 2: 20330 STEVENS CREEK BLVD. CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-18 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001224091 MAHONEY DAVID L C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Common Stock 2017-07-18 4 M 0 6091 2.23 A 1141764 I Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Common Stock 2017-07-18 4 S 0 6091 12.5002 D 1135673 I Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Common Stock 2017-07-19 4 M 0 16915 2.23 A 1152588 I Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Common Stock 2017-07-19 4 S 0 16915 12.5012 D 1135673 I Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Stock Option (Right to Buy) 2.23 2017-07-18 4 M 0 6091 0.00 D 2018-06-09 Common Stock 6091 16915 D Stock Option (Right to Buy) 2.23 2017-07-19 4 M 0 16915 0.00 D 2018-06-09 Common Stock 16915 0 D These transactions are made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.50 to $12.505 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Fully exercisable. /s/ G. Charles Robb, Attorney-in-Fact for David L. Mahoney 2017-07-20